Efficacy and safety of necitumumab continuation therapy in phase 3 SQUIRE study
Authors
Ciuleanu, TSocinski, M
Obasaju, C
Luft, A
Szczesna, A
Szafranski, W
Ramlau, R
Balint, B
Kazarnowicz, A
Kazarnowicz, A
Molinier, O
Depenbrock, H
Nanda, S
Paz-Ares, L
Thatcher, Nick
Affiliation
Institute of Oncology Ion Chiricuta and Umf Iuliu Hatieganu, Cluj Napoca/RomaniaIssue Date
2015